
Bethan Rose Jenkins, Cannabis News Writer/Editorial
December 5, 2018
Filed under News, Research, Showcase
Cannabis Science, Inc. (OTC: CBIS), a U.S. developer of cannabinoid-based medicines, has proudly confirmed receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders (ADHD), and P...
Tags: Canadian cannabis stocks, cannabis business, cannabis in canada, cannabis in the u.s., cannabis industry, cannabis laws, cannabis legalization, cannabis market, cannabis products, cannabis research, cannabis science, CBD, cbd oil, congress, Donald Trump, global cannabis industry, Io, Jeff Sessions, legal cannabis, legal weed industry, medical cannabis, medical weed, recreational weed, THC

Bethan Rose Jenkins, Cannabis News Writer/Editorial
August 7, 2018
Filed under Research
California boasts a fierce and competitive cannabis market that is expected to surpass $5.1 billion in market value over the next year. As cannabis consumption rises in The Golden State, so does the need for cannabis research into the plant’s health and safety effects.
This is why a team of devo...
Tags: adult-use cannabis, Assembly Bill 266, Attorney General Jeff Sessions, california cannabis market, California Legislature, cannabidiol, cannabis, cannabis agriculture, cannabis cultivation, cannabis dispensary, cannabis driving, cannabis industry, cannabis laws, cannabis medicine, cannabis research, cannabis sales in north america, cannabis science, CBD, Center for Medicinal Cannabis Research, cmcr, Donald Trump, effects of cannabis on driving, lauren phinney, medical cannabis, Medical Marijuana Regulation and Safety Act, medicinal cannabis, north american cannabis sales, Obama Administration, recreational cannabis, social cannabis, states can legalize cannabis, Tetrahydrocannabinol, THC, thomas marcotte, uc san diego, ucsd